Last reviewed · How we verify

NCT03875833

Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest

Withdrawn NA Last updated 22 May 2023
What this trial tests

NA trial testing Collagen Nerve Wrap Conduit in Head and Neck Neoplasms. Withdrawn.

Timeline
9 October 2020
Primary endpoint
1 January 2024
1 January 2024

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date9 October 2020
Primary completion1 January 2024
Estimated completion1 January 2024

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Head and Neck Neoplasms or Dysesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether collagen nerve conduits placed on exposed radial and ulnar nerves during radial and ulnar forearm free flap harvests will reduce the occurrence and degree of sensory nerve deficit.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Modern Trends for Peripheral Nerve Repair and Regeneration: Beyond the Hollow Nerve Guidance Conduit.
    Carvalho CR, Oliveira JM, Reis RL. · · 2019 · cited 201× · PMID 31824934 · DOI 10.3389/fbioe.2019.00337

Verify or expand the search:

Other recruiting trials for Head and Neck Neoplasms

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03875833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing